HOWL Earnings
Latest Revenue21.0M
Latest Net Income3.7M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.08 | 21.0M | 3.7M | — | +120.0% |
| Q1 2026 | -$0.28 | 0 | -13532000 | — | +30.0% |
| Q4 2025 | -$0.17 | 0 | -8381000 | — | +63.0% |
| Q3 2025 | -$0.36 | 0 | -16370000 | — | +5.3% |
| Q2 2025 | -$0.40 | 0 | -17982000 | -100.0% | +0.0% |
| Q1 2025 | -$0.40 | 0 | -18089000 | -100.0% | -2.6% |
| Q4 2024 | -$0.46 | 0 | -20400000 | -100.0% | -39.4% |
| Q3 2024 | -$0.38 | 0 | -16673000 | -100.0% | -65.2% |
| Q2 2024 | -$0.40 | 1.1M | -17249000 | — | — |
| Q1 2024 | -$0.39 | 742.0K | -16193000 | — | — |
| Q4 2023 | -$0.33 | 1.5M | -12003000 | — | — |
| Q3 2023 | -$0.23 | 5.9M | -8285000 | — | — |
Werewolf Therapeutics (HOWL) — Earnings